Metformin: an emerging new therapeutic option for targeting cancer stem cells and metastasis
about
Salinomycin as a drug for targeting human cancer stem cellsThe association between type 2 diabetes mellitus and women cancer: the epidemiological evidences and putative mechanismsPPAR Gamma in Neuroblastoma: The Translational Perspectives of Hypoglycemic DrugsRacial disparity in colorectal cancer: Gut microbiome and cancer stem cellsThe neurobiology of the Prader-Willi phenotype of fragile X syndromeImpact of glucose-lowering agents on the risk of cancer in type 2 diabetic patients. The Barcelona case-control studyResponse of breast cancer cells and cancer stem cells to metformin and hyperthermia alone or combinedDiabetes and cancer: Associations, mechanisms, and implications for medical practice.Metformin against cancer stem cells through the modulation of energy metabolism: special considerations on ovarian cancer.Modulation by metformin of molecular and histopathological alterations in the lung of cigarette smoke-exposed miceChallenges and future directions in therapeutics for pancreatic ductal adenocarcinoma.Diabetes mellitus and ovarian cancer: more complex than just increasing riskDiabetes mellitus and colorectal cancer prognosis: a meta-analysisMultiple drug resistance due to resistance to stem cells and stem cell treatment progress in cancer (Review).Metformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion currentMetformin suppresses pancreatic tumor growth with inhibition of NFκB/STAT3 inflammatory signaling.Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: treating cancer like an infectious disease.Metformin inhibits gastric cancer cells metastatic traits through suppression of epithelial-mesenchymal transition in a glucose-independent manner.Epithelial-to-mesenchymal transition (EMT) confers primary resistance to trastuzumab (Herceptin).Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in vitro and in vivo.5-fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits.Metformin selectively affects human glioblastoma tumor-initiating cell viability: A role for metformin-induced inhibition of Akt.Diabetes and risk of cancer.Temozolomide in combination with metformin act synergistically to inhibit proliferation and expansion of glioma stem-like cells.Extracellular acidity strengthens mesenchymal stem cells to promote melanoma progressionMetformin for primary colorectal cancer prevention in patients with diabetes: a case-control study in a US population.Metformin restores crizotinib sensitivity in crizotinib-resistant human lung cancer cells through inhibition of IGF1-R signaling pathway.New molecules and old drugs as emerging approaches to selectively target human glioblastoma cancer stem cells.Glioma stem cells: markers, hallmarks and therapeutic targeting by metformin.Cancer stem cells: a potential target for cancer therapy.The Role of Aspirin, Vitamin D, Exercise, Diet, Statins, and Metformin in the Prevention and Treatment of Colorectal Cancer.Inhibition of Epithelial-Mesenchymal Transition and Metastasis by Combined TGFbeta Knockdown and Metformin Treatment in a Canine Mammary Cancer Xenograft Model.Metformin Elicits Antitumor Effects and Downregulates the Histone Methyltransferase Multiple Myeloma SET Domain (MMSET) in Prostate Cancer Cells.Metformin upregulates E-cadherin and inhibits B16F10 cell motility, invasion and migration.Comparative proteome profiling of breast tumor cell lines by gel electrophoresis and mass spectrometry reveals an epithelial mesenchymal transition associated protein signature.Impact of Diabetes on Outcomes of Sorafenib Therapy for Hepatocellular Carcinoma.Metformin anti-tumor effect via disruption of the MID1 translational regulator complex and AR downregulation in prostate cancer cells.Metformin inhibition of neuroblastoma cell proliferation is differently modulated by cell differentiation induced by retinoic acid or overexpression of NDM29 non-coding RNA.Model-based unsupervised learning informs metformin-induced cell-migration inhibition through an AMPK-independent mechanism in breast cancerHigh Recovery of Functional Islets Stored at Low and Ultralow Temperatures.
P2860
Q21285139-0EA650CE-E296-4B80-ABA7-92F53FFF67C2Q27026813-703E7129-1EA7-4B3E-AFB7-01BDF5D335AAQ28066756-51307302-C7E7-464D-A24A-0C9E175B0808Q28075465-E9DFF350-0D5D-4726-B49D-7F4A4E1BBAF5Q28078294-5AF8119C-8A20-497C-9A84-A40AECC58038Q28535372-A58588A6-36F9-4088-8A07-35AF1113798DQ28539523-02DA741B-245E-4C91-ABF0-2C085AED6D72Q33759594-A11BF6F7-E331-4AAD-A7CD-35A6EEC37281Q33890763-233F6EB0-03C9-4EB2-A900-3D1B6D497510Q33913626-1173A530-4186-463E-812E-CFEFBDB99056Q34431614-ACD5BAAE-9C17-405F-A06A-A3014CFDEA8DQ34615282-803259AE-7B58-427D-B4A4-D47692B6005AQ34656583-80FA441E-2CFA-4B8D-A631-BDFDA3DF893EQ34795591-269BA5DA-3D8A-4F47-A73D-D8A1BFFB071BQ34957274-317A7455-6BC4-4B92-808C-E5D2D96E9237Q35439302-93459BC8-EE86-4F26-9F93-BF139B4C1E9BQ35741510-2838BA50-6F43-4C40-9D5C-226627E0199AQ36320084-DD373687-3A98-47D0-B806-F1B5B9FE53CFQ36426509-6E7CE10D-86A2-4515-9C3A-A928652296E1Q36545028-2146679D-9BBD-458A-9DD8-7D96ACE7D095Q36561571-94B6DFBA-6FF9-4E6B-B537-05D2398CE4A2Q36604614-3997EA44-83D4-48C8-9459-28BC3C4B977AQ36637909-31627D69-393C-46FE-BE88-2A4141290293Q36741098-5EC3BDB6-AE1A-4FCA-8A6B-D95DCEE92772Q36780789-8C394B55-3397-41D6-99E6-EDE1861CC2EEQ36901902-F6E47181-617F-48B8-8682-0593A045E64FQ37376294-5D6911E8-9C8A-4C26-A92D-3F735BEA1FBEQ38187997-321BFD66-6359-4516-9E86-D46B87C4C23DQ38244345-D32430C4-9C33-4CE5-B9E8-65FACE31C00AQ38476034-B57698BD-83C4-4DE8-A2D9-DA7D1F849DACQ38549743-A2EC8151-AB7D-415D-AB92-D3C3B75B3565Q38721748-CAECA403-41BB-4D90-A37F-D36B6B11AB7AQ38740526-D3764D7C-E3AD-4315-B95C-A623B5C8F3F2Q38815463-A251BF43-04DE-43E3-86AA-11AEAB142D6EQ39224654-4DAAF86D-AC78-4702-8CCB-23F6CCAB087BQ39510564-4E521F0F-3F05-414A-9756-7548746A3142Q41967169-BB996C63-AB03-4566-A108-511649062632Q42019935-AFE68D47-BBA3-4D9A-97A6-6E7BF6B7D4BCQ42265576-561D8F3A-DAD2-49CD-95D5-49E48AF6F186Q42291020-77C3D3B6-6AD5-4E52-BABE-5315E3E6B368
P2860
Metformin: an emerging new therapeutic option for targeting cancer stem cells and metastasis
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Metformin: an emerging new the ...... ncer stem cells and metastasis
@ast
Metformin: an emerging new the ...... ncer stem cells and metastasis
@en
type
label
Metformin: an emerging new the ...... ncer stem cells and metastasis
@ast
Metformin: an emerging new the ...... ncer stem cells and metastasis
@en
prefLabel
Metformin: an emerging new the ...... ncer stem cells and metastasis
@ast
Metformin: an emerging new the ...... ncer stem cells and metastasis
@en
P2093
P2860
P356
P1433
P1476
Metformin: an emerging new the ...... ncer stem cells and metastasis
@en
P2093
Adnan Munkarah
Ramandeep Rattan
Rouba Ali Fehmi
P2860
P304
P356
10.1155/2012/928127
P577
2012-06-04T00:00:00Z